"Inventages provided the investment partnership we were looking for. Having taken the decision in late 2010 to seek venture capital investment to accelerate Shield's development plans, it was critical that the partner we eventually chose shared our work ethic and implicitly understood our business, especially the great opportunity we have to deliver patient benefit and create significant shareholder value. We believe we have found this match with Inventages. I was also keen to choose just one key partner and not have the investment syndicated, thereby avoiding over-complicated Board structures and misaligned investors."
portfolio
CEOs
Carl Sterritt, Shield Therapeutics
"Inventages provided the investment partnership we were looking for. Having taken the decision in late 2010 to seek venture capital investment to accelerate Shield's development plans, it was critical that the partner we eventually chose shared our work ethic and implicitly understood our business, especially the great opportunity we have to deliver patient benefit and create significant shareholder value. We believe we have found this match with Inventages. I was also keen to choose just one key partner and not have the investment syndicated, thereby avoiding over-complicated Board structures and misaligned investors."
